SLNCF
SLNCF
GB00B9GTXM62
Silence Therapeutics, Plc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 559.000 43.258.000
98.7%
Cost of Revenue 215.000 11.810.000
98.2%
Gross Profit 344.000 31.448.000
98.9%
90.097.000 94.767.000
4.9%
Operating Income -89.753.000 -63.319.000
41.7%
Pretax Income -88.601.000 -44.464.000
99.3%
Net Income Common Stockholders -88.612.000 -45.309.000
95.6%
-- --
--
-- --
--
ende